Disorder Related to Cardiac Transplantation Clinical Trial
Official title:
Follow-up Registry of Heart Transplant Recipients, to Determine Long Term Outcome and Need for Further Interventional and Non-interventional Procedures
NCT number | NCT02347371 |
Other study ID # | VSZR - 001 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | January 2015 |
Est. completion date | May 2020 |
Verified date | April 2021 |
Source | Semmelweis University Heart and Vascular Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
The purpose of this registry is to determine the long term outcomes of heart transplantations performed at the Semmelweis University Heart and Vascular Center. All eventual interventional and non-interventional procedures will be accounted for and summarized.
Status | Completed |
Enrollment | 11 |
Est. completion date | May 2020 |
Est. primary completion date | May 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Heart transplant recipient - >18 years old - Signed informed consent - Cared for at the Semmelweis University Heart and Vascular Center Exclusion Criteria: - Denies consent to registry |
Country | Name | City | State |
---|---|---|---|
Hungary | Semmelweis University Heart and Vascular Center | Budapest |
Lead Sponsor | Collaborator |
---|---|
Semmelweis University Heart and Vascular Center |
Hungary,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Outcome of heart transplantation as measured by all-cause mortality | All-cause mortality will be assessed after transplantation in all participating subjects. | 5 years | |
Secondary | Morbidity after heart transplantation | All invasive procedures that are required after initial surgery will be tracked and accounted for. | 5 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT02503566 -
Assessment of Cardiac Allograft Vasculopathy by Optical Coherence Tomography
|
N/A | |
Completed |
NCT00377962 -
Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation
|
Phase 4 |